South San Francisco – October 19, 2026 -- ACROBiosystems unveiled a 4-day sequence-to-affinity screening service, CHO-DirectTM, at its ACRO Innovation Day x AI on October 13, 2026, targeting the experimental validation bottleneck in AI-driven biologics discovery. The service closes the wet-lab loop in as few as 7 days when combined with developability and characterization work.

San Diego – September 24, 2026 -- ACROBiosystems has launched CHO-Direct, a rapid high-throughput affinity validation service that delivers antibody affinity data in as little as four days from sequence submission, alongside a broader infrastructure platform called ACRO AIx aimed at AI-driven drug discovery (AIDD).

Zurich – September 19, 2026 -- ACROBiosystems has established a dedicated office within The HIVE Innovation Center on Campus Grand Parc in Villejuif, deepening its footprint in France's oncology research corridor. The move, facilitated by real estate operator Kadans Science Partner, gives the roughly 1,000-employee biotechnology group direct proximity to biotechs, hospitals, and translational research institutes clustered around Paris-Saclay.